Adult's Lived Experience Using the Insulin-Only Bionic Pancreas.

IF 4.1 Q2 ENDOCRINOLOGY & METABOLISM

Journal of Diabetes Science and Technology Pub Date : 2024-08-30 DOI:10.1177/19322968241274364

Kimberly P Garza, Kelsey R Howard, Marissa Feldman, Jill Weissberg-Benchell

{"title":"Adult's Lived Experience Using the Insulin-Only Bionic Pancreas.","authors":"Kimberly P Garza, Kelsey R Howard, Marissa Feldman, Jill Weissberg-Benchell","doi":"10.1177/19322968241274364","DOIUrl":null,"url":null,"abstract":"Background: The purpose of this study was to assess adults' perspectives after using the insulin-only Bionic Pancreas (BP) during a 13-week pivotal trial. Automated insulin delivery (AID) systems show promise in improving glycemic outcomes and reducing disease burden for those with type 1 diabetes mellitus (T1D). Understanding the lived experience of those using the BP can help to inform education and uptake of AID devices.Methods: Adults ages 19 to 75 (n = 40) participated in age-specific focus groups (19-25, 26-40, 41-64, and 65+) exploring their experiences, thoughts, and feelings about using the BP. Three authors analyzed the focus group data using a hybrid thematic approach.Results: Qualitative analysis of focus groups revealed 14 sub-themes falling into four major themes (diabetes burden, managing glucose levels, daily routine, and user experience). Although participants' overall experience was positive, some reported struggles related to managing out-of-range glucose levels and challenges with the system responding to unique meal schedules and exercise regimens.Conclusion: This study captures patient perspectives regarding their experiences with a new AID system. Patient voice can inform device development and educational approaches for people with T1D. Identifying which patients may benefit the most from wearing this system may facilitate patient/clinician discussions regarding insulin delivery systems that best meet their individualized needs and expectations that may support device uptake and continued use.","PeriodicalId":15475,"journal":{"name":"Journal of Diabetes Science and Technology","volume":null,"pages":null},"PeriodicalIF":4.1000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes Science and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/19322968241274364","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The purpose of this study was to assess adults' perspectives after using the insulin-only Bionic Pancreas (BP) during a 13-week pivotal trial. Automated insulin delivery (AID) systems show promise in improving glycemic outcomes and reducing disease burden for those with type 1 diabetes mellitus (T1D). Understanding the lived experience of those using the BP can help to inform education and uptake of AID devices.

Methods: Adults ages 19 to 75 (n = 40) participated in age-specific focus groups (19-25, 26-40, 41-64, and 65+) exploring their experiences, thoughts, and feelings about using the BP. Three authors analyzed the focus group data using a hybrid thematic approach.

Results: Qualitative analysis of focus groups revealed 14 sub-themes falling into four major themes (diabetes burden, managing glucose levels, daily routine, and user experience). Although participants' overall experience was positive, some reported struggles related to managing out-of-range glucose levels and challenges with the system responding to unique meal schedules and exercise regimens.

Conclusion: This study captures patient perspectives regarding their experiences with a new AID system. Patient voice can inform device development and educational approaches for people with T1D. Identifying which patients may benefit the most from wearing this system may facilitate patient/clinician discussions regarding insulin delivery systems that best meet their individualized needs and expectations that may support device uptake and continued use.

查看原文本刊更多论文

成人使用纯胰岛素仿生胰腺的生活体验。

研究背景本研究的目的是评估成人在为期 13 周的关键试验期间使用胰岛素专用仿生胰腺 (BP) 后的看法。胰岛素自动给药 (AID) 系统有望改善 1 型糖尿病 (T1D) 患者的血糖结果并减轻疾病负担。了解胰岛素自动给药系统使用者的生活经历有助于为胰岛素自动给药系统的教育和使用提供参考：方法：19 至 75 岁的成年人（n = 40）参加了特定年龄的焦点小组（19-25 岁、26-40 岁、41-64 岁和 65 岁以上），探讨他们使用血压计的经历、想法和感受。三位作者采用混合主题方法对焦点小组数据进行了分析：对焦点小组的定性分析显示，14 个子主题分为四大主题（糖尿病负担、控制血糖水平、日常生活和用户体验）。虽然参与者的总体体验是积极的，但也有一些人报告了在管理超出范围的血糖水平方面遇到的困难，以及系统在应对独特的膳食安排和运动方案方面遇到的挑战：这项研究捕捉到了患者对新辅助诊断系统使用体验的看法。患者的声音可以为 T1D 患者的设备开发和教育方法提供参考。确定哪些患者可从佩戴该系统中获益最多，可促进患者/医师就胰岛素给药系统进行讨论，以最大程度地满足他们的个性化需求和期望，从而支持设备的吸收和持续使用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Diabetes Science and Technology Medicine-Internal Medicine

CiteScore

7.50

自引率

12.00%

发文量

148

期刊介绍： The Journal of Diabetes Science and Technology (JDST) is a bi-monthly, peer-reviewed scientific journal published by the Diabetes Technology Society. JDST covers scientific and clinical aspects of diabetes technology including glucose monitoring, insulin and metabolic peptide delivery, the artificial pancreas, digital health, precision medicine, social media, cybersecurity, software for modeling, physiologic monitoring, technology for managing obesity, and diagnostic tests of glycation. The journal also covers the development and use of mobile applications and wireless communication, as well as bioengineered tools such as MEMS, new biomaterials, and nanotechnology to develop new sensors. Articles in JDST cover both basic research and clinical applications of technologies being developed to help people with diabetes.